Patients with a higher tumor burden in the blood (>3 CTC/mL) showed a trend to poorer OS (11.5 months vs. 20 months).
also in 53,322 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.